215 related articles for article (PubMed ID: 7853199)
1. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
Raber J; Koob GF; Bloom FE
J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
[TBL] [Abstract][Full Text] [Related]
2. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling.
Raber J; Bloom FE
J Neurosci; 1994 Oct; 14(10):6187-95. PubMed ID: 7523633
[TBL] [Abstract][Full Text] [Related]
3. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
4. IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala.
Raber J; Pich EM; Koob GF; Bloom FE
Neuroendocrinology; 1994 Mar; 59(3):208-17. PubMed ID: 8159270
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response.
Raber J; Koob GF; Bloom FE
Neurochem Int; 1997; 30(4-5):455-63. PubMed ID: 9106261
[TBL] [Abstract][Full Text] [Related]
6. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
Kageyama K; Hanada K; Iwasaki Y; Sakihara S; Nigawara T; Kasckow J; Suda T
J Endocrinol; 2007 Nov; 195(2):199-211. PubMed ID: 17951532
[TBL] [Abstract][Full Text] [Related]
8. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG
Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
10. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
Karanth S; Lyson K; McCann SM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and interleukin-1beta mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus.
Hsieh CH; Li HY; Chen JC
Neuroscience; 2010 Feb; 165(4):1191-202. PubMed ID: 20004705
[TBL] [Abstract][Full Text] [Related]
13. Nicotine-induced norepinephrine release in hypothalamic paraventricular nucleus and amygdala is mediated by N-methyl-D-aspartate receptors and nitric oxide in the nucleus tractus solitarius.
Zhao R; Chen H; Sharp BM
J Pharmacol Exp Ther; 2007 Feb; 320(2):837-44. PubMed ID: 17093131
[TBL] [Abstract][Full Text] [Related]
14. Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine.
Chen XQ; Du JZ; Wang YS
Regul Pept; 2004 Jul; 119(3):221-8. PubMed ID: 15120484
[TBL] [Abstract][Full Text] [Related]
15. Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation.
Raber J; Bloom FE
Neuroscience; 1996 Apr; 71(3):747-59. PubMed ID: 8867047
[TBL] [Abstract][Full Text] [Related]
16. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
Wilson MA; Biscardi R; Smith MD; Wilson SP
J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
Tsagarakis S; Holly JM; Rees LH; Besser GM; Grossman A
Endocrinology; 1988 Oct; 123(4):1962-9. PubMed ID: 2970959
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine but not epinephrine stimulates the release of corticotropin-releasing factor from in vitro superfused rat hypothalamus.
Orliaguet G; Mélik Parsadaniantz S; Lenoir V; Duval P; Kerdelhué B
J Neurosci Res; 1995 Oct; 42(2):236-41. PubMed ID: 8568924
[TBL] [Abstract][Full Text] [Related]
20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
